The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting.

Seung-Hoon Lee Kyung Ho Lee Tae Sun Han Chang-Su Han Won-Myong Bahk Soo-Jung Lee Ashwin A Patkar Prakash S Masand Chi-Un Pae

Published in: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology (2024)

: This study has shown additional benefit of ARPA treatment for MDDA patients in routine practice. However, adequately-powered and well-controlled studies are necessary for generalization of the present findings.

Keyphrases

major depressive disorder
bipolar disorder
end stage renal disease
healthcare
chronic kidney disease
newly diagnosed
primary care
patient reported outcomes
combination therapy
quality improvement
case control